Drug Approvals
The latest news about Drug Approvals: headlines, AI summaries and the full story from every source.
- Hengrui Pharma Reports Strong Growth and Strategic GLP-1 Pipeline Advancements in Q3 2026
- Gilead Sciences Receives Multiple FDA Approvals and Label Expansions
- Teva Gains FDA Approval for Monthly Olanzapine Injection to Treat Schizophrenia
- Eli Lilly's Olumiant approved for severe alopecia areata in children aged 12 and older
- FDA Approves Merck's Welireg and Eisai's Lenvima Combination for Advanced Kidney Cancer
- Merck Receives FDA Approval to Update Label for Winrevair
- Pharming Group Expands Joenja's Pediatric Label Amid RUCONEST Revenue Decline
- FDA Approves Telix Pharmaceuticals' Pixclara Imaging Drug
- Takeda receives FDA approval for rusfertide as treatment for polycythemia vera
- Novo Nordisk Receives European Approval for Wegovy Pill as First Oral GLP-1 Therapy
- Merck Receives U.S. FDA Approval for Cholesterol Pill Lipfendra
- Merck's Cholesterol Drug Lipfendra Approved by FDA
- Regenxbio Shares Rise After Report FDA Will Reverse Rejection of Rare-Disease Drug
- Alvotech Resubmits U.S. Applications for Biosimilars Targeting J&J's Simponi and Regeneron's Eylea
- AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO®
- Agios Pharmaceuticals Shares Rise on Strong Q1 Earnings and Aqvesme Launch Progress
- Eli Lilly Reports Strong Q1 Results and Raises Full-Year Outlook Due to GLP-1 Sales Growth